www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

  Home>News Center>Bizchina
       
 

Drug maker expects sales growth
By Zhu Baoxia (China Daily)
Updated: 2004-02-27 10:10

Novartis AG, the Switzerland-based pharmaceutical researcher and developer, expects an annual 20-30 per cent growth of sales in China in the next five years.

Sales for the world's fifth-largest drug maker are expected to grow by 42.6 per cent this year, an increase of 28.8 percentage points over last year.

In 2002, sales on the Chinese mainland reached 1.14 billion yuan (US$137 million), an increase of 13.8 per cent over the previous year, according to Paul Lau, president of Novartis China branch.

This optimism is based on a series of plans that Novartis AG has made for its business expansion strategy on the Chinese mainland for the next few years.

In order to fulfill these targets, explained Lau, Novartis AG plans to bring its affiliated company Sandoz to China to explore the huge OTC market, further enlarge the scale of its production base in Changping, located in suburban Beijing, and launch at least two new patented drugs in China Sandostatin LAR, a treatment for cancer and Visudyne for age-related vision dysfunction.

Sandoz, another leading chemical/life science giant, was established in 1886. It was merged with two other companies, Ciba and Geigy, to create Novartis AG in 1996.

The simultaneous merger of Ciba-Geigy and Sandoz was the largest corporate deal in the world.

Starting in 2002, Novartis AG put all of its OTC pharmaceutical business under the Sandoz name. Last year, Sandoz reported an increase of 47 per cent in sales globally.

Sandoz will set up an office in China to carry out OTC business. At this time, Sandoz has no direct business with the Chinese mainland, Lau said. He did not give more detail about where and when the office will open.

He confirmed that the Novartis AG executive board has approved the further expansion of the production base in Changping in northern Beijing.

The expansion is expected to be completed before 2007.

With a total investment of 120 million yuan (US$14 million), the production capacity of the new plant is expected to triple from the present level and the variety of products will also increase, according to James Liu, president of Beijing Novartis Pharmaceutical Co Ltd.



 
  Story Tools  
   
  Related Stories  
   
China to intensify regulation over medicines
Manufacturers, Exporters, Wholesalers - Global trade starts here.

 

Advertisement
         
主站蜘蛛池模板: 欧美成人精品不卡视频在线观看 | 国产首页精品 | 欧美性另类69xxxx极品 | 欧美综合视频在线 | 久久久久久中文字幕 | 欧美日韩在线永久免费播放 | 武松大战潘金莲三级在线 | 黄色上床网站 | 国产精品久久久久影院色 | 国产成人精品999在线观看 | 在线不卡一区二区 | 请看一下欧美一级毛片 | 一本色道久久综合亚洲精品高清 | 九九色网站 | 色爽爽爽爽爽爽爽爽 | 男人天堂视频网 | 欧美成人在线影院 | 国产精品自拍合集 | 91精品久久久久久久久网影视 | 女人叉开腿让男人捅 | 三级国产在线 | 成人看的午夜免费毛片 | 亚洲精品456在线播放无广告 | 美女被免费视频网站a国产 美女被免费网站视频软件 美女被免费网站在线软件 美女被免费网站在线视频软件 | 精品精品国产欧美在线观看 | 国产特黄一级毛片特黄 | 杨晨晨福利视频 | 亚洲精品一区二区久久 | 成人精品第一区二区三区 | 99视频精品免费99在线 | 在线观看成年人免费视频 | 老司机亚洲精品影院在线 | 国产精品免费大片一区二区 | 久久国产精品歌舞团 | 国产成人美女福利在线观看 | 一级做a爰片久久毛片 | 欧美精品在线一区二区三区 | 久久精品人人爽人人爽快 | 亚洲国产精品综合久久 | 国产精品二区三区 | 国产精品v在线播放观看 |